![Fleury SA Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/bovespa/flry3.png?tr=w-200)
Fleury SA
BOVESPA:FLRY3
![Fleury SA Logo](https://ik.imagekit.io/kkbzr2uz4cp/stock/bovespa/flry3.png)
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Realty Income Corp
NYSE:O
|
Real Estate
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/bovespa/flry3.png)
Fleury SA
Net Income (Common)
Fleury SA
Net Income (Common) Peer Comparison
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/bovespa/onco3.png)
![](https://ik.imagekit.io/kkbzr2uz4cp/stock/bovespa/aalr3.png)
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
![]() |
Fleury SA
BOVESPA:FLRY3
|
Net Income (Common)
R$497.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
22%
|
![]() |
Oncoclinicas do Brasil Servicos Medicos SA
BOVESPA:ONCO3
|
Net Income (Common)
R$223.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
![]() |
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
|
Net Income (Common)
-R$270.4m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
D
|
Diagnosticos da America SA
BOVESPA:DASA3
|
Net Income (Common)
-R$1.2B
|
CAGR 3-Years
-140%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fleury SA's Net Income (Common)?
Net Income (Common)
497.9m
BRL
Based on the financial report for Mar 31, 2024, Fleury SA's Net Income (Common) amounts to 497.9m BRL.
What is Fleury SA's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
22%
Over the last year, the Net Income (Common) growth was 71%. The average annual Net Income (Common) growth rates for Fleury SA have been 16% over the past three years , 9% over the past five years , and 22% over the past ten years .